PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Controlled release of baricitinib from a thermos-responsive hydrogel system inhibits inflammation by suppressing JAK2/STAT3 pathway in acute spinal cord injury.

Rat / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 33385822 ↗2020Reported benefit

Controlled release of baricitinib from a thermos-responsive hydrogel system inhibits inflammation by suppressing JAK2/STAT3 pathway in acute spinal cord injury.

RatSpinal cord injuryUnspecifiedSprague-DawleyLocal injection of the hydrogel into the injured spinal cordInjected at the time of injury surgery

Model: Acute spinal cord injury in rats

The baricitinib hydrogel inhibited JAK2 and STAT3 phosphorylation, suppressed inflammatory cytokines and reduced neuronal apoptosis early after injury, and later promoted functional recovery.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.